| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-33236 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NB100-82243-0.025ml | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-44034 | |||
| BSA Free | NBP2-52929-25ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-90327-25ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-85795-25ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-44033 | |||
| BSA Free | NBP2-30458-25ul | |||
![Western Blot: ATF2 [p Thr71] Antibody (103C411.2) [NB100-56594] - Detection of ATF2 phosphorylation in HeLa cell lysate with phospho ATF2 antibody. Lane A. Untreated cell lysate; Lane B. HeLa cells treated with TNF for 1 hr.](http://images.novusbio.com/fullsize/ATF2-p-Thr71-Antibody-103C411-2-Western-Blot-NB100-56594-img0003.jpg "<b>Biological Strategies Validation. </b>Western Blot: ATF2 [p Thr71] Antibody (103C411.2) [NB100-56594] - Detection of ATF2 phosphorylation in HeLa cell lysate with phospho ATF2 antibody. Lane A. Untreated cell lysate; Lane B. HeLa cells treated with TNF for 1 hr.")
![Western Blot: Rel B Antibody [NBP2-20123] - Sample (30 ug of whole cell lysate) A: NIH-3T3 7. 5% SDS PAGE gel, diluted at 1:10000.](http://images.novusbio.com/fullsize/Rel-B-Antibody-Western-Blot-NBP2-20123-img0002.jpg "Western Blot: Rel B Antibody [NBP2-20123] - Sample (30 ug of whole cell lysate) A: NIH-3T3 7. 5% SDS PAGE gel, diluted at 1:10000.")
![Western Blot: Rabbit Polyclonal RelB Antibody [NBP2-20123] - Whole cell lysates from MDA-MB-231, SUM159, MCF-7 and HEK293T cells were loaded with 50 ug/lane. 10% SDS-PAGE. RRS1 Antibody (NBP2-49323) was used for primary antibody: 1:1000, 4C, overnight. Image from a verified customer review.](http://images.novusbio.com/fullsize/antibody/nbp2-20123_rabbit-polyclonal-relb-antibody-western-blot-311202415821..jpg)
![Western Blot: RelB Antibody [NBP2-20123] - Various whole cell extracts (30 ug) were separated by 7.5% SDS-PAGE, and the membrane was blotted with RelB antibody (NBP2-20123) diluted at 1:1000. The HRP-conjugated anti-rabbit IgG antibody was used to detect the primary antibody.](http://images.novusbio.com/fullsize/nbp2-20123_rabbit-polyclonal-relb-antibody-91020242075935.jpg)
![Western Blot: Tau [p Ser396] Antibody [NB100-82243] - Extracts from mouse brain tissue using Tau(p Ser396) Antibody and same antibody preincubated with blocking peptide](http://images.novusbio.com/fullsize/Tau-[p-Ser396]-Antibody-Western-Blot-NB100-82243-img0003.jpg "Western Blot: Tau [p Ser396] Antibody [NB100-82243] - Extracts from mouse brain tissue using Tau(p Ser396) Antibody and same antibody preincubated with blocking peptide")
![Immunohistochemistry: Tau [p Ser396] Antibody [NB100-82243] - Immunohistochemical analysis of paraffin-embedded rat hippocampal region tissue from a model with Alzheimer's Disease using NB100-82243.](http://images.novusbio.com/fullsize/nb100-82243_rabbit-polyclonal-tau-p-ser396-antibody-103202523321010.jpg)
![Western Blot: p38 alpha [p Tyr182] Antibody [NB100-82097] - Human breast cancer cell line MDA-MB-231 was treated with different doses of p38 inhibitor and the expression of phospho-p38 and total p38 were detected by Western blot. Image from verified customer review.](http://images.novusbio.com/fullsize/p38-alpha-[p-Tyr182]-Antibody-Western-Blot-NB100-82097-img0008.jpg "<b>Biological Strategies Validation. </b>Western Blot: p38 alpha [p Tyr182] Antibody [NB100-82097] - Human breast cancer cell line MDA-MB-231 was treated with different doses of p38 inhibitor and the expression of phospho-p38 and total p38 were detected by Western blot. Image from verified customer review.")
![<b>Biological Strategies Validation. </b>Western Blot: p38 alpha [p Tyr182] Antibody [NB100-82097] - Analysis of extracts from Hela cells untreated or treated with UV for the indicated times, using P38 MAPK (Phospho-Tyr182) antibody.](http://images.novusbio.com/fullsize/p38-alpha-[p-Tyr182]-Antibody-Western-Blot-NB100-82097-img0001.jpg)
![<b>Biological Strategies Validation. </b>Western Blot: p38 alpha [p Tyr182] Antibody [NB100-82097] - Analysis of extracts from Hela cells, treated with TNFa or calf intestinal phosphatase (CIP).](http://images.novusbio.com/fullsize/p38-alpha-[p-Tyr182]-Antibody-Western-Blot-NB100-82097-img0005.jpg)
![Immunohistochemistry-Paraffin: p38 alpha [p Tyr182] Antibody [NB100-82097] - Analysis of paraffin-embedded human breast carcinoma tissue, using NB100-82097(left) or the same antibody preincubated with blocking peptide(right).](http://images.novusbio.com/fullsize/nb100-82097_rabbit-polyclonal-p38-alpha-p-tyr182-antibody-10320252332107.jpg)
![Western Blot: STAT3 [p Tyr705] Antibody (RM261) [NBP2-61588] - Western Blot of A431 cell lysates, nontreated (-) or treated (+) with EGF, using NBP2-61588, showed Phospho-Stat3 (Tyr705) in EGF-treated A431 cells.](http://images.novusbio.com/fullsize/STAT3-p-Tyr705-Antibody-RM261-Western-Blot-NBP2-61588-img0006.jpg "Western Blot: STAT3 [p Tyr705] Antibody (RM261) [NBP2-61588] - Western Blot of A431 cell lysates, nontreated (-) or treated (+) with EGF, using NBP2-61588, showed Phospho-Stat3 (Tyr705) in EGF-treated A431 cells.")
![Immunohistochemistry-Paraffin: STAT3 [p Tyr705] Antibody (RM261) [NBP2-61588] - Human intestine. Image from verified customer review.](http://images.novusbio.com/fullsize/STAT3-p-Tyr705-Antibody-RM261-Immunohistochemistry-Paraffin-NBP2-61588-img0005.jpg)
![Immunohistochemistry-Paraffin: STAT3 [p Tyr705] Antibody (RM261) [NBP2-61588] - Immunohistochemical staining of formalin fixed and paraffin embedded Human breast cancer tissue sections using NBP2-61588.](http://images.novusbio.com/fullsize/nbp2-61588_rabbit-monoclonal-stat3-p-tyr705-antibody-rm261-immunohistochemistry-paraffin-189202523485315.png)
![Western Blot: MEF2A Antibody (1C8) [H00004205-M15] - Analysis of MEF2A expression in MCF-7 (Cat # L046V1).](http://images.novusbio.com/fullsize/MEF2A-Antibody-1C8-Western-Blot-H00004205-M15-img0008.jpg "Western Blot: MEF2A Antibody (1C8) [H00004205-M15] - Analysis of MEF2A expression in MCF-7 (Cat # L046V1).")
![Immunocytochemistry/Immunofluorescence: MEF2A Antibody (1C8) [H00004205-M15] - Analysis of monoclonal antibody to MEF2A on MCF-7 cell. Image from verified customer review](http://images.novusbio.com/fullsize/MEF2A-Antibody-1C8-Immunocytochemistry-Immunofluorescence-H00004205-M15-img0009.jpg)
![Western Blot: MEF2A Antibody (1C8) [H00004205-M15] - Analysis of MEF2A expression in HepG2 (Cat # L019V1).](http://images.novusbio.com/fullsize/MEF2A-Antibody-1C8-Western-Blot-H00004205-M15-img0007.jpg)
![Immunocytochemistry/Immunofluorescence: MEF2A Antibody (1C8) [H00004205-M15] - Analysis of monoclonal antibody to MEF2A on MCF-7 cell. Antibody concentration 10 ug/ml](http://images.novusbio.com/fullsize/MEF2A-Antibody-1C8-Immunocytochemistry-Immunofluorescence-H00004205-M15-img0006.jpg)
![ELISA: MEF2A Antibody (1C8) [H00004205-M15] - Detection limit for recombinant GST tagged MEF2A is approximately 0.3ng/ml as a capture antibody.](http://images.novusbio.com/fullsize/MEF2A-Antibody-1C8-ELISA-H00004205-M15-img0004.jpg)
![Western Blot: LYRIC Antibody (CL0397) [NBP2-52929] - Lane 1: Marker [kDa], Lane 2: Human cell line U-251 MG](http://images.novusbio.com/fullsize/LYRIC-Antibody-CL0397-Western-Blot-NBP2-52929-img0008.jpg "Western Blot: LYRIC Antibody (CL0397) [NBP2-52929] - Lane 1: Marker [kDa], Lane 2: Human cell line U-251 MG")
![Immunocytochemistry/Immunofluorescence: LYRIC Antibody (CL0397) [NBP2-52929] - Staining of U-251 cells using the Anti-MTDH monoclonal antibody, showing specific staining in the endoplasmic reticulum in green. Microtubule- and nuclear probes are visualized in red and blue, respectively (where available).](http://images.novusbio.com/fullsize/LYRIC-Antibody-CL0397-Immunocytochemistry-Immunofluorescence-NBP2-52929-img0009.jpg)
![Immunohistochemistry-Paraffin: LYRIC Antibody (CL0397) [NBP2-52929] - Staining of human testis shows strong cytoplasmic positivity in seminiferous tubules.](http://images.novusbio.com/fullsize/LYRIC-Antibody-CL0397-Immunohistochemistry-Paraffin-NBP2-52929-img0007.jpg)
![Immunohistochemistry-Paraffin: LYRIC Antibody (CL0397) [NBP2-52929] - Staining of human breast cancer shows strong cytoplasmic immunoreactivity in cancer cells.](http://images.novusbio.com/fullsize/LYRIC-Antibody-CL0397-Immunohistochemistry-Paraffin-NBP2-52929-img0001.jpg)
![Immunohistochemistry-Paraffin: LYRIC Antibody (CL0397) [NBP2-52929] - Staining of human colorectal cancer shows cytoplasmic immunoreactivity in tumor cells.](http://images.novusbio.com/fullsize/LYRIC-Antibody-CL0397-Immunohistochemistry-Paraffin-NBP2-52929-img0002.jpg)
![Immunohistochemistry-Paraffin: LYRIC Antibody (CL0397) [NBP2-52929] - Staining of human liver cancer shows granular cytoplasmic immunoreactivity in tumor cells.](http://images.novusbio.com/fullsize/LYRIC-Antibody-CL0397-Immunohistochemistry-Paraffin-NBP2-52929-img0003.jpg)
![Immunohistochemistry-Paraffin: LYRIC Antibody (CL0397) [NBP2-52929] - Staining of human placenta shows absence of staining in the placental trophoblast (negative control).](http://images.novusbio.com/fullsize/LYRIC-Antibody-CL0397-Immunohistochemistry-Paraffin-NBP2-52929-img0004.jpg)
![Immunohistochemistry-Paraffin: LYRIC Antibody (CL0397) [NBP2-52929] - Staining of human prostate cancer shows strong cytoplasmic positivity in glandular cells.](http://images.novusbio.com/fullsize/LYRIC-Antibody-CL0397-Immunohistochemistry-Paraffin-NBP2-52929-img0005.jpg)
![Immunohistochemistry-Paraffin: LYRIC Antibody (CL0397) [NBP2-52929] - Staining of human rectum shows strong cytoplasmic positivity in glandular cells.](http://images.novusbio.com/fullsize/LYRIC-Antibody-CL0397-Immunohistochemistry-Paraffin-NBP2-52929-img0006.jpg)
![Immunocytochemistry/Immunofluorescence: LYRIC Antibody [NBP1-90327] - Immunofluorescent staining of human cell line A-431 shows localization to endoplasmic reticulum.](http://images.novusbio.com/fullsize/LYRIC-Antibody-Immunocytochemistry-Immunofluorescence-NBP1-90327-img0007.jpg "Immunocytochemistry/Immunofluorescence: LYRIC Antibody [NBP1-90327] - Immunofluorescent staining of human cell line A-431 shows localization to endoplasmic reticulum.")
![Immunohistochemistry-Paraffin: LYRIC Antibody [NBP1-90327] - Staining of human placenta shows moderate to strong cytoplasmic positivity in decidual cells.](http://images.novusbio.com/fullsize/LYRIC-Antibody-Immunohistochemistry-Paraffin-NBP1-90327-img0011.jpg)
![Immunohistochemistry-Paraffin: LYRIC Antibody [NBP1-90327] - Staining of human cerebellum shows moderate to strong cytoplasmic positivity in purkinje cells.](http://images.novusbio.com/fullsize/LYRIC-Antibody-Immunohistochemistry-Paraffin-NBP1-90327-img0012.jpg)
![<b>Independent Antibodies Validation. </b>Western Blot: LYRIC Antibody [NBP1-90327] - Analysis using Anti-MTDH antibody NBP1-90327 (A) shows similar pattern to independent antibody NBP1-90328 (B).](http://images.novusbio.com/fullsize/LYRIC-Antibody-Western-Blot-NBP1-90327-img0013.jpg)
![Immunocytochemistry/Immunofluorescence: MEF2D Antibody [NBP1-85795] - Immunofluorescent staining of human cell line U-2 OS shows localization to nucleoplasm & vesicles.](http://images.novusbio.com/fullsize/MEF2D-Antibody-Immunocytochemistry-Immunofluorescence-NBP1-85795-img0006.jpg "Immunocytochemistry/Immunofluorescence: MEF2D Antibody [NBP1-85795] - Immunofluorescent staining of human cell line U-2 OS shows localization to nucleoplasm & vesicles.")
![Immunohistochemistry-Paraffin: MEF2D Antibody [NBP1-85795] - Staining of human liver shows no positivity in hepatocytes as expected.](http://images.novusbio.com/fullsize/MEF2D-Antibody-Immunohistochemistry-Paraffin-NBP1-85795-img0017.jpg)
![<b>Orthogonal Strategies Validation. </b>Immunohistochemistry-Paraffin: MEF2D Antibody [NBP1-85795] - Analysis in human skeletal muscle and liver tissues. Corresponding MEF2D RNA-seq data are presented for the same tissues.](http://images.novusbio.com/fullsize/MEF2D-Antibody-Immunohistochemistry-Paraffin-NBP1-85795-img0014.jpg)
![<b>Independent Antibodies Validation. </b>Immunohistochemistry-Paraffin: MEF2D Antibody [NBP1-85795] - Staining of human kidney, liver, placenta and skeletal muscle using Anti-MEF2D antibody NBP1-85795 (A) shows similar protein distribution across tissues to independent antibody NBP1-85788 (B).](http://images.novusbio.com/fullsize/MEF2D-Antibody-Immunohistochemistry-Paraffin-NBP1-85795-img0015.jpg)
![Immunohistochemistry-Paraffin: MEF2D Antibody [NBP1-85795] - Staining of human kidney shows strong nuclear positivity in cells in glomeruli.](http://images.novusbio.com/fullsize/MEF2D-Antibody-Immunohistochemistry-Paraffin-NBP1-85795-img0016.jpg)
![Western Blot: LYRIC Antibody (CL0401) [NBP2-30458] - Lane 1: Marker [kDa]. Lane 2: Human cell line U-251 MG](http://images.novusbio.com/fullsize/LYRIC-Antibody-CL0401-Western-Blot-NBP2-30458-img0008.jpg "Western Blot: LYRIC Antibody (CL0401) [NBP2-30458] - Lane 1: Marker [kDa]. Lane 2: Human cell line U-251 MG")
![Immunocytochemistry/Immunofluorescence: LYRIC Antibody (CL0401) [NBP2-30458] - Staining of U-251 cells using the Anti-MTDH monoclonal antibody, showing specific staining in the endoplasmic reticulum in green. Microtubule- and nuclear probes are visualized in red and blue, respectively (where available). Antibody staining is shown in green.](http://images.novusbio.com/fullsize/LYRIC-Antibody-CL0401-Immunocytochemistry-Immunofluorescence-NBP2-30458-img0016.jpg)
![Immunohistochemistry-Paraffin: LYRIC Antibody (CL0401) [NBP2-30458] - Staining of human placenta shows absence of staining in the trophoblast layer (negative control).](http://images.novusbio.com/fullsize/LYRIC-Antibody-CL0401-Immunohistochemistry-Paraffin-NBP2-30458-img0015.jpg)
![Immunohistochemistry-Paraffin: LYRIC Antibody (CL0401) [NBP2-30458] - Staining of human cerebral cortex shows moderate to strong cytoplasmic positivity in glial cells.](http://images.novusbio.com/fullsize/LYRIC-Antibody-CL0401-Immunohistochemistry-Paraffin-NBP2-30458-img0009.jpg)
![Immunohistochemistry-Paraffin: LYRIC Antibody (CL0401) [NBP2-30458] - Staining of human testis shows strong cytoplasmic immunoreactivity in the seminiferous tubules.](http://images.novusbio.com/fullsize/LYRIC-Antibody-CL0401-Immunohistochemistry-Paraffin-NBP2-30458-img0010.jpg)
![Immunohistochemistry-Paraffin: LYRIC Antibody (CL0401) [NBP2-30458] - Staining of human colon shows moderate cytoplasmic positivity in the glandular cells.](http://images.novusbio.com/fullsize/LYRIC-Antibody-CL0401-Immunohistochemistry-Paraffin-NBP2-30458-img0011.jpg)
![Immunohistochemistry-Paraffin: LYRIC Antibody (CL0401) [NBP2-30458] - Staining of human colorectal cancer shows moderate cytoplasmic immunoreactivity in cancer cells.](http://images.novusbio.com/fullsize/LYRIC-Antibody-CL0401-Immunohistochemistry-Paraffin-NBP2-30458-img0012.jpg)
![Immunohistochemistry-Paraffin: LYRIC Antibody (CL0401) [NBP2-30458] - Staining of human breast cancer (ductal carcinoma) shows strong cytoplasmic positivity in cancer cells.](http://images.novusbio.com/fullsize/LYRIC-Antibody-CL0401-Immunohistochemistry-Paraffin-NBP2-30458-img0013.jpg)
![Immunohistochemistry-Paraffin: LYRIC Antibody (CL0401) [NBP2-30458] - Staining of human liver cancer (hepatocellular carcinoma) shows moderate cytoplasmic immunoreactivity in cancer cells.](http://images.novusbio.com/fullsize/LYRIC-Antibody-CL0401-Immunohistochemistry-Paraffin-NBP2-30458-img0014.jpg)